Chilake is a modern hybrid-indica cultivar derived exclusively from its parent strain, Chilavender. This variety is categorized as a high-yield producer that reaches maturity after a 63-day flowering period. It is well-suited for both indoor and outdoor cultivation environments, presenting a moderate challenge for growers. Beyond its primary botanical lineage, the plant has served as a progenitor for newer lines, most notably appearing in the cross-breeding project known as Chilake x Double Dalai.

The chemical complexity of Chilake is defined by a broad terpene profile that begins with dominant concentrations of myrcene, followed by pinene, caryophyllene, and limonene. Secondary and tertiary notes include beta-pinene, humulene, linalool, ocimene, caryophyllene-oxide, camphene, isopulegol, nerolidol, and terpinolene. This specific arrangement of compounds dictates the strain's sensory profile, resulting in a nuanced aromatic and flavor experience that balances earthier base notes with sharper, botanical top notes.

As a THC-dominant cultivar, Chilake is primarily sought for its ability to induce states characterized by relaxation, calmness, and mental focus. These therapeutic properties make it a viable option for users managing physical pain, stress, or difficulties with sleep. By combining reliable growth characteristics with a targeted effect profile, this hybrid serves as a versatile tool for both recreational and medicinal applications.